scholarly journals Assessing myocardial circumferential strain using cardiovascular magnetic resonance after magnetic resonance-conditional cardiac resynchronization therapy

2020 ◽  
Vol 15 (10) ◽  
pp. 1954-1959
Author(s):  
Hideo Arai ◽  
Masateru Kawakubo ◽  
Kenichi Sanui ◽  
Hiroshi Nishimura ◽  
Toshiaki Kadokami
Author(s):  
Francisco Leyva ◽  
Charlotte Manisty

Cardiovascular magnetic resonance (CMR) can inform on the aetiology of heart failure, global cardiac function, and myocardial viability, all of which are essential in cardiac resynchronization therapy (CRT). Late gadolinium enhancement (LGE)-CMR allows quantification of myocardial scarring and characterization of the pattern of scar, both of which may be useful in risk stratification. In addition, the ability of CMR to localize myocardial scar and provide reliable measures of segmental motion and deformation is being applied to targeting left ventricular lead deployment. The development of CMR-compatible devices may permit the use of CMR in the optimization of CRT after implantation.


2020 ◽  
Vol 4 (3) ◽  
pp. 163-172
Author(s):  
Sanshuai Chang ◽  
Yi He ◽  
Hui Wang ◽  
Fei Guo ◽  
Qiang Lv ◽  
...  

Background: Left bundle branch block (LBBB)-induced cardiomyopathy has been proposed, but the association between LBBB and cardiac resynchronization therapy (CRT) response remains unclear and practical criteria for selecting CRT candidates are needed.Methods: One hundred and seventeen consecutive heart failure patients were reviewed, 24 of whom received CRT. Only two patients had a clear temporal relation between cardiomyopathy and LBBB.Results: Compared with the patient with “cardiomyopathy-induced LBBB,” the patient with “LBBB-induced cardiomyopathy” had higher left ventricular (LV) wall thickness, higher LV wall thickening rate, higher peak circumferential strain, and longer peak circumferential strain delay. The LV deformation patterns in the two patients were obviously distinct on cardiovascular magnetic resonance tissue tracking. During follow-up, the patient with LBBB-induced cardiomyopathy had a good response to CRT (LV ejection fraction 23 before CRT vs. 30% at 6 months vs. 29 at 12 months vs. 32% at 18 months; LV end-diastolic diameter 77 mm before CRT vs. 66 mm at 6 months vs. 62 mm at 12 months vs. 63 mm at 18 months), and the other patient had no response to CRT (LV ejection fraction 29 before CRT vs. 29% at 6 months vs. 26 at 12 months vs. 22% at 24 months; LV end-diastolic diameter 85 mm before CRT vs. 88 mm at 6 months vs. 85 mm at 12 months vs. 84 mm at 24 months).Conclusion: The temporal relation between cardiomyopathy and LBBB could be a determinant for CRT response. Cardiovascular magnetic resonance tissue tracking may be a useful tool to identify the chronological order and a principal consideration for selecting candidates for CRT. Larger prospective clinical trials are needed to study the prevalence of, time course of, and risk factors for LBBB-induced cardiomyopathy.


Sign in / Sign up

Export Citation Format

Share Document